http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-108452312-B

Outgoing Links

Predicate Object
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2430-02
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-025
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L27-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L27-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L27-08
filingDate 2018-02-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2021-03-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2021-03-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-108452312-B
titleOfInvention Preparation method of graphene quantum dot and calcium carbonate composite nano-microspheres
abstract The invention provides a preparation method of graphene quantum dot and calcium carbonate composite nano microspheres. (1) Mixing the graphene quantum dots with a calcium salt solution and dimethyl carbonate; (2) heating in water bath at 20-22 ℃, and stirring for 1-5 min; (3) adding a sodium hydroxide solution into the mixed solution obtained in the step (2), stirring for 30s, and standing; (4) and (3) carrying out suction filtration, washing with absolute ethyl alcohol, flushing the product from the filter membrane into a centrifugal tube with the absolute ethyl alcohol, and carrying out vacuum drying at 30-80 ℃ for 24h to obtain the graphene quantum dot and calcium carbonate composite nanospheres. The hollow calcium carbonate microsphere prepared by the invention has the particle size range of about 100-500 nm, has a hollow structure and a solid structure, a huge specific surface area and good cell compatibility, can be prepared into a drug carrier or a human tissue engineering scaffold, and is applied to the field of bone tissue medical treatment.
priorityDate 2018-02-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453467280
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538410
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID297
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559581
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453213080
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10112
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419519407
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID271
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID409060395
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559506
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID12021
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5284359
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID702
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14798

Total number of triples: 34.